Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer

<p>PET and PET/CT using [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled c...

Full description

Bibliographic Details
Main Author:	S. Schwarzenböck, M. Souvatzoglou, B. J. Krause
Format:	Article
Language:	English
Published:	Ivyspring International Publisher 2012-01-01
Series:	Theranostics
Online Access:	http://www.thno.org/v02p0318.htm

Similar Items

Dynamic 11C-Choline PET / CT for the primary diagnosis of prostate cancer
by: Shay Golan, et al.

Is there the role of 18F-choline PET/CT in prostate cancer patients?
by: Hodolič Marina
Published: (2012-01-01)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
by: A. Matti, et al.
Published: (2017-10-01)

Choline PET/CT in Multiple Myeloma
by: Charles Mesguich, et al.
Published: (2020-05-01)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by 11C-Choline PET/CT
by: Kazuhiro Kitajima, et al.
Published: (2018-01-01)

18F-DCFPyL PET/CT in primary staging of prostate cancer
by: Maurits Wondergem, et al.
Published: (2018-10-01)

11C–Choline PET / CT in the detection of prostate cancer relapse in patients with rising PSA
by: I. P. Aslanidis, et al.
Published: (2015-09-01)

Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
by: Maria Picchio, Paolo Castellucci
Published: (2012-01-01)

A population-based study of the clinical utility of 18F–choline PET/CT for primary metastasis staging of high-risk prostate cancer
by: Henrik Kjölhede, et al.
Published: (2017-11-01)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
by: Charlotte L. Deijen, et al.
Published: (2021-09-01)

Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?
by: Hossein Jadvar
Published: (2012-01-01)

11C-Choline PET/CT and PSA kinetics
by: Castellucci Paolo, et al.
Published: (2012-01-01)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
by: Kazuhiro Kitajima, et al.
Published: (2021-01-01)

Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT
by: Kazuhiro Kitajima, et al.
Published: (2021-03-01)

The Role of [<sup>18</sup>F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [<sup>11</sup>C]Choline PET/CT and Histopathological Analysis
by: Lucia Zanoni, et al.
Published: (2021-03-01)

Metachronous colon tumor detected utilizing 18F-choline PET/CT in a patient with prostate cancer
by: A. Moreno-Ballesteros, et al.
Published: (2021-10-01)

Assessment of lymph nodes and prostate status using early dynamic curves with 18F-choline PET/CT in prostate cancer
by: Cédric eMathieu, et al.
Published: (2015-09-01)

Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
by: Jing-Ren Tseng, et al.
Published: (2018-01-01)

Diagnostic accuracy of 18F-Fluciclovine PET/CT in primary lymph node staging of prostate cancer
by: R.J. Hoekstra, et al.
Published: (2020-11-01)

Value of 11C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
by: Shuoming Zhou, et al.
Published: (2021-02-01)

Staging of breast cancer with PET/CT
by: J S Moller, et al.
Published: (2008-03-01)

Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.
by: Yu Guo, et al.
Published: (2018-01-01)

A prospective study determining and comparing the diagnostic accuracy of fluoride-PET/CT, choline-PET/CT, whole-body bone SPECT/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer
by: Eva Dyrberg, et al.
Published: (2018-10-01)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
by: Belka Claus, et al.
Published: (2010-03-01)

C-11 Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma – a Comparative Analysis
by: Chanisa Chotipanich, et al.
Published: (2015-01-01)

C-11 Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma – a Comparative Analysis
by: Chanisa Chotipanich, et al.
Published: (2015-01-01)

Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
by: Yi Liu, et al.
Published: (2019-01-01)

Optimized Application of 68Ga-Prostate-Specific Membrane Antigen-617 Whole-Body PET/CT and Pelvic PET/MR in Prostate Cancer Initial Diagnosis and Staging
by: Chunxia Qin, et al.
Published: (2021-05-01)

Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications
by: Morand Piert, et al.
Published: (2018-03-01)

<sup>18</sup>F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
by: Nicoletta Urbano, et al.
Published: (2019-10-01)

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer
by: Urs J. Muehlematter, et al.
Published: (2018-05-01)

Imaging Comparison between 18F-FDG-PET/CT and 18F-Flouroethyl Choline PET/CT in Rare Case of Thymus Carcinoma Exhibiting a Positive Choline Uptake
by: Mustafa Takesh, et al.
Published: (2013-01-01)

Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
by: Thomas Franz Fassbender, et al.
Published: (2020-06-01)

ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF ¹¹C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER
by: M. A. Rybalov, et al.
Published: (2015-12-01)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
by: Akram Al-Ibraheem, et al.
Published: (2009-01-01)

Detection rates of recurrent prostate cancer: Gallium (Ga)-labelled prostate-specific membrane antigen choline PET/CT scans. A systematic review
by: Masood Moghul, et al.
Published: (2019-01-01)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
by: Timothy N. Kwan, et al.
Published: (2021-06-01)

Correction to: impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer
by: Urs J. Muehlematter, et al.
Published: (2018-07-01)

Dual-stage 18F-fluorocholine PET/CT scanning for biochemical recurrences of prostate cancer
by: M. B. Dolgushin, et al.
Published: (2015-06-01)

Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [18F] choline PET/MRI.
by: Axel Wetter, et al.
Published: (2014-01-01)